GlobeNewswire by notified

ACTO Secures $18M Financing to Accelerate Growth and Strengthen Position as #1 Learning Platform in Life Sciences

Share

TORONTO, July 07, 2022 (GLOBE NEWSWIRE) -- ACTO, the omnichannel learning and enablement platform for life sciences, today announced the closing of a US$18 million equity financing. The investment was led by Questa Capital, a healthcare venture growth equity firm that actively invests in healthcare and life sciences software. With this investment, Questa joins ACTO's existing investors: Resolve Growth Partners, Salesforce Ventures, Panache Ventures, and MaRS Investment Accelerator Fund1.

This investment by Questa Capital validates the large market opportunity to transform critical learning experiences and sales enablement approaches in the life sciences industry. The company will use the proceeds of the investment to accelerate the growth and scale of ACTO and explore potential business and partnership opportunities.

“The rapid growth of our customer community demonstrates the industry’s interest and hunger for a new way of delivering commercial learning and development. Trends driving this shift include the increase in clinical data and the demand for flexible access to information in the flow of work. We are happy to meet these needs with the only omnichannel learning platform for the life sciences industry,” says Parth Khanna, CEO of ACTO. He added, “We are thrilled to have Questa Capital join us on this journey and look forward to delighting our customers with innovative solutions, such as our recently announced conversational assistant LAICA™, to make commercial learning in Life Sciences easier and more engaging.”

ACTO is disrupting the learning experience and sales enablement landscape in life sciences, which is primed for a new, modern and user-accessible solution to training and enabling learners in pharma. This round of funding allows ACTO to expand and enhance capabilities to accelerate its technology as the #1 life sciences-focused learning enablement platform. 

“At Questa, we are passionate about investing in innovative and well-positioned companies that empower the healthcare and life sciences industries to improve patient outcomes. We are excited to partner with Parth and the outstanding management team at ACTO to invest in the company’s strategic growth plan. With experienced leadership and cutting-edge SaaS technology, ACTO is serving a market ripe for a better approach,” says Ryan Drant, Founder and Managing Partner at Questa Capital, who was recently recognized as a top healthcare investor of 2022 by GrowthCap Advisory2.

The current financing brings ACTO's total invested capital to more than US$30 million. ACTO continues to experience robust user and revenue growth, including a 500% increase in annual recurring revenue since 2018.

About ACTO
Global life science companies rely on ACTO's AI-powered SaaS platform to transform their field teams’ learning journey and experience at scale. Commercial and clinical leaders leverage ACTO's omnichannel learning platform to educate and engage learners through unified educational experiences across the care continuum. Building an ecosystem for life sciences, ACTO maintains a network of partnerships with content agencies, data providers, technology companies, and more. To learn more about ACTO, please visit acto.com.

For media inquiries or to request a media interview, please contact:
Swati Mehta, Account Director
PR Associates
smehta@prassociates.com
403-804-0768

About Questa Capital
Questa Capital is a venture growth equity firm focusing on investments in expansion-stage healthcare companies. Questa seeks out disruptive, technology-enabled business models that help improve patient lives, streamline market inefficiencies, and provide better quality care. The firm partners with superior management teams to help build innovative market leaders in the healthcare technology, services and medical devices sectors. Questa is led by industry veterans in healthcare investment and operations who have invested in and advised more than 50 growth-stage companies. More information is available at www.questacapital.com.

  1. https://www.acto.com/newsroom/acto-closes-11-5m-series-a-round-to-accelerate-virtual-transformation-for-life-sciences-companies/
  2. https://www.questacapital.com/questa-managing-partners-honored-as-top-25-healthcare-investors-in-2022/

Photos accompanying this announcement are available at https://www.globenewswire.com/NewsRoom/AttachmentNg/39e47304-b45b-4459-bd98-c29fe7f75e3f

https://www.globenewswire.com/NewsRoom/AttachmentNg/a1b2304b-a3c1-4d77-9ab6-121918aea911

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Mandalay Resources Provides Target Release Date for Second Quarter 2022 Financial Results and Conference Call8.8.2022 22:35:00 CEST | Press release

TORONTO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Mandalay Resources Corporation (“Mandalay” or “the Company”) (TSX: MND, OTCQB: MNDJF) today announced that its first quarter 2022 financial results will be released after market close on August 10, 2022, followed by a conference call with Dominic Duffy, President and Chief Executive Officer of Mandalay, for investors and analysts on August 11, 2022, at 8:00 AM (Toronto time). Analysts and interested investors are invited to participate using the following dial-in numbers: Participant Number (Toll free):877 407 8289Conference ID:13731674 A replay of the conference call will be available until 11:59 PM (Toronto time), August 25, 2022, and can be accessed using the following dial-in number: Encore Toll Free Dial-in Number:877 660 6853Encore ID:13731674 For Further Information: Dominic Duffy President and Chief Executive Officer Edison Nguyen Director, Business Valuations and Investor Relations Contact: 647.260.1566 ext. 1 About Mandalay Resources

FRO - 2022 Annual General Meeting8.8.2022 22:30:00 CEST | Press release

Frontline Ltd. (the “Company”) advises that the 2022 Annual General Meeting of the Company will be held on September 30, 2022. The record date for voting at the Annual General Meeting is set to August 19, 2022. The notice, agenda and associated material will be distributed prior to the meeting. Hamilton, Bermuda August 8, 2022 This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

GOGL – Notice of Annual General Meeting 20228.8.2022 22:30:00 CEST | Press release

Golden Ocean Group Limited (the “Company”) advises that the 2022 Annual General Meeting of the Company will be held on September 30, 2022. The record date for voting at the Annual General Meeting is set to August 19, 2022. The notice, agenda and associated material will be distributed prior to the meeting. August 8, 2022 The Board of Directors Golden Ocean Group Limited Hamilton, Bermuda This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Infinera Completes $373.75 Million Convertible Senior Notes Offering and Repurchases Approximately $300 Million of 2024 Convertible Notes8.8.2022 22:23:04 CEST | Press release

SAN JOSE, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Infinera (NASDAQ: INFN) announced today the closing of its previously announced offering of 3.75% convertible senior notes due 2028 (the “2028 Notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). After the exercise in full of the option to purchase additional 2028 Notes, the aggregate principal amount of 2028 Notes issued in the offering was $373.75 million, with the Company receiving net proceeds (after fees and other expenses) of approximately $362.50 million. The Company used approximately $283.62 million of the net proceeds from this offering to repurchase, including the payment of accrued and unpaid interest, approximately $300 million in aggregate principal amount of its 2.125% Convertible Senior Notes due 2024 in privately negotiated transactions concurrently with the offering. The company intends to use the remaining net proc

CrossAmerica Partners LP Reports Second Quarter 2022 Results8.8.2022 22:15:00 CEST | Press release

Allentown, PA, Aug. 08, 2022 (GLOBE NEWSWIRE) -- CrossAmerica Partners LP Reports Second Quarter 2022 Results Reported Second Quarter 2022 Operating Income of $21.1 million and Net Income of $14.0 million compared to Operating Income of $8.2 million and Net Income of $4.8 million for the Second Quarter 2021Generated Second Quarter 2022 Adjusted EBITDA of $41.4 million and Distributable Cash Flow of $32.4 million compared to Second Quarter 2021 Adjusted EBITDA of $29.7 million and Distributable Cash Flow of $25.0 millionReported Second Quarter 2022 Gross Profit for the Wholesale Segment of $55.0 million compared to $44.2 million of Gross Profit for the Second Quarter 2021Distributed 342.8 million wholesale fuel gallons during the Second Quarter 2022 at an average wholesale fuel margin per gallon of 11.8 cents compared to 331.6 million wholesale fuel gallons at an average wholesale fuel margin per gallon of 9.2 cents during the Second Quarter 2021, an increase of 3% in gallons distribute